Year: 2016
Type: review
Abstract: The most common mood disorders are major depressive disorders and bipolar disorders (BD). The pathophysiology of BD is complex, multifactorial, and not fully understood. Creation of new hypotheses in the field gives impetus for studies and for finding new biomarkers for BD. Conversely, new biomarkers facilitate not only diagnosis of a disorder and monitoring of biological effects of treatment, but also formulation of new hypotheses about the causes and pathophysiology of the BD. BD is characterized by multiple associations between disturbed brain development, neuroplasticity, and chronobiology, caused by: genetic and environmental factors; defects in apoptotic, immune-inflammatory, neurotransmitter, neurotrophin, and calcium-signaling pathways; oxidative and nitrosative stress; cellular bioenergetics; and membrane or vesicular transport. Current biological hypotheses of BD are summarized, including related pathophysiological processes and key biomarkers, which have been associated with changes in genetics, systems of neurotransmitter and neurotrophic factors, neuroinflammation, autoimmunity, cytokines, stress axis activity, chronobiology, oxidative stress, and mitochondrial dysfunctions. Here we also discuss the therapeutic hypotheses and mechanisms of the switch between depressive and manic state.
DOI: 10.1111/pcn.12476
Institutions: Charles University, General University Hospital in Prague
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: bipolar disorder, biomarkers, pathophysiology, neuroinflammation, autoimmunity, cytokines, oxidative stress, mitochondrial dysfunction, neurotrophic factors, neurotransmitters, calcium signaling, chronobiology, stress axis, apoptosis, neuroplasticity, brain development, therapeutic mechanisms
Open Access status: bronze
Award: G8310290818
OpenAlex ID: W2553608151
